Frequently asked questions
The global cellulite treatment market was valued at USD 1354.8 Million in 2022.
The cellulite treatment market is expected to grow at a CAGR of 11.5% between 2023 and 2030, reaching USD 3236.48 Million in 2030.
Anti-cellulite creams are the leading segment by product type, holding over 44% share in value in 2022.
The topical creams and lotions segment governs the global demand for cellulite treatment, holding a massive share of over 20% in 2022.
The spas and wellness centers segment will post the highest CAGR over the projection period.
With more than one-third of the market in 2022, North America is driving the expansion of the cellulite treatment industry.
The top players include Merz Pharma, Hologic Inc (Cynosure), Syneron Medical, Zimmer Aesthetics, Alma Lasers, Cymedics, Nubway, AbbVie Inc., Galderma SA, Bausch Health Companies Inc., and Others.
The major market drivers of the cellulite treatment industry include increasing aesthetic consciousness, advancements in treatment technologies, and the growing demand for non-invasive and minimally invasive procedures.
The major market restraints of the cellulite treatment industry include varied treatment outcomes among individuals and the high cost of cellulite treatments, which can be a barrier for many potential patients.
The major market opportunities of the cellulite treatment industry include expanding non-invasive and minimally invasive treatments and capitalizing on the trend of at-home cellulite treatment devices to cater to consumer preferences and technological advancements.